View in EDS HTML Full Text PDF Full Text

Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.
Authors: Dillard CM; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee H; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kalariya N; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subramanian N; UTHealth Houston McGovern Medical School, Houston, TX, USA., Pasvolsky O; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ferreri C; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaballa M; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thomas SK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weber DM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Becnel M; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kaufman G; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Qazilbash M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Orlowski RZ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hildebrandt MAT; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mhildebr@mdanderson.org., Patel KK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kpatel1@mdanderson.org.
Source: Blood cancer journal [Blood Cancer J] 2026 Apr 13; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 13.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41974660
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dillard+CM%22">Dillard CM</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kalariya+N%22">Kalariya N</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Subramanian+N%22">Subramanian N</searchLink>; UTHealth Houston McGovern Medical School, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pasvolsky+O%22">Pasvolsky O</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ferreri+C%22">Ferreri C</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gaballa+M%22">Gaballa M</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+SK%22">Thomas SK</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Weber+DM%22">Weber DM</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Becnel+M%22">Becnel M</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kaufman+G%22">Kaufman G</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Qazilbash+M%22">Qazilbash M</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Orlowski+RZ%22">Orlowski RZ</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hildebrandt+MAT%22">Hildebrandt MAT</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mhildebr@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Patel+KK%22">Patel KK</searchLink>; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kpatel1@mdanderson.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2026 Apr 13; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 Apr 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41974660
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-026-01489-9
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dillard CM
      – PersonEntity:
          Name:
            NameFull: Lee H
      – PersonEntity:
          Name:
            NameFull: Kalariya N
      – PersonEntity:
          Name:
            NameFull: Subramanian N
      – PersonEntity:
          Name:
            NameFull: Pasvolsky O
      – PersonEntity:
          Name:
            NameFull: Ferreri C
      – PersonEntity:
          Name:
            NameFull: Gaballa M
      – PersonEntity:
          Name:
            NameFull: Thomas SK
      – PersonEntity:
          Name:
            NameFull: Weber DM
      – PersonEntity:
          Name:
            NameFull: Becnel M
      – PersonEntity:
          Name:
            NameFull: Kaufman G
      – PersonEntity:
          Name:
            NameFull: Qazilbash M
      – PersonEntity:
          Name:
            NameFull: Orlowski RZ
      – PersonEntity:
          Name:
            NameFull: Hildebrandt MAT
      – PersonEntity:
          Name:
            NameFull: Patel KK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 04
              Text: 2026 Apr 13
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1